Federal Register Notice: FDA Office of Minority Health, Office of Women’s Health, CBER, CDER, and CDRH will hold a public meeting 2/29 seeking feedback and recommendations from patient groups, consumer groups, regulated industry, academia, and other interested parties on FDA’s progress in implementing the “Action Plan to Enhance the Collection and Availability of Demographic Subgroup Data,” required under the Food and Drug Administration Safety and Innovation Act.” The meeting will be held, from 9 a.m. to 4 p.m. at FDA’s White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room (B & C), Silver Spring, MD. Contact FDA at email: FDASIA907@fda.hhs.gov. To view this notice, click here.